❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Cancer Genetics ❭ Translational studies on solid tumours [Helland] ❭ Clinical trials ❭ NIPU ❭

Malignant mesothelioma treated with immune checkpoint inhibitors 
with or without cancer vaccine (the NIPU-study)

– a phase II randomised clinical and translational trial

  • EudraCT number: 2019-002721-30 
  • Clinicaltrials.gov: NCT04300244
Background/study objectives
Study design
Collaborative partners
Update/publications
Scroll to top

Home Dept. of Cancer Genetics Translational studies on solid tumours [Helland]

  • Group members
  • Clinical trials
    • DART
    • NIPU
    • COM-IT-2
    • MATRIX-RARE
    • IMPRESS-Norway
  • Translational studies
  • Publications
  • News

Recent publications

Filippi AR, Bar J, Christoph DC, Field JK, Fietkau R, Garassino MC, Garrido P, Haakensen VD, Kao S, McDonald F, Mornex F, Moskovitz M, Peters S, Van Den Heuvel MM, Vercauter P, Smit HJM, Solomon B, Chander P, Qiao Y, Faria J, Girard N (2026)
Radiotherapy patterns and factors associated with pneumonitis in PACIFIC-R, a real-world study of patients with unresectable stage III non-small-cell lung cancer treated with durvalumab after chemoradiotherapy
Clin Transl Radiat Oncol, 58, 101138
DOI 10.1016/j.ctro.2026.101138, PubMed 41809542

Bjørgo E, Ånensen N, Fagereng GL, Russnes HG, Smeland S, Taskén K, Helland Å (2026)
Merging clinical research and standard healthcare - Nordic Precision Cancer Medicine Symposium 2025
Acta Oncol, 65, 181-185
DOI 10.2340/1651-226X.2026.45168, PubMed 41778669

Rakaee M, Nassar AH, Tafavvoghi M, Jabar F, Bou Farhat E, Adib E, Andersen S, Busund LR, Pøhl M, Helland Å, Gusev A, Ricciuti B, Sholl LM, Donnem T, Kwiatkowski DJ (2026)
Ancestry-Associated Performance Variability of Open-Source AI Models for EGFR Prediction in Lung Cancer
JAMA Oncol (in press)
DOI 10.1001/jamaoncol.2025.6430, PubMed 41678173

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)